Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population. It is performed with the help of uterine fibroid embolization agents, delivered to the tumor by micro-catheters. The embolization agents block the arteries supplying blood to the tumor and force them to shrink. The increased awareness about the uterine fibroids amongst women and popularity of minimally invasive procedure will drive the global market for uterine fibroid embolization agents. In addition, the fact that UFE allows woman to preserve their uterus, otherwise not possible with full or even partial hysterectomy will further drive the market. The global Uterine Fibroid Embolization Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Uterine Fibroid Embolization Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Uterine Fibroid Embolization Agents market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Uterine Fibroid Embolization Agents in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Uterine Fibroid Embolization Agents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: Astellas Pharma Nippon Kayaku Pfizer Boston Scientific Corporation Merit Medical Systems Cook Medical ... Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type Gelatin Sponge Polyvinyl Alcohol (PVA) Particles Trisacryl Gelatin Microspheres (TAGM) Polymethyl Methacrylate (PMMA) Microspheres Others Segment by Application Clinical Research Institutes Hospital Surgical Centers Others
Table of Contents Executive Summary 1 Industry Overview of Uterine Fibroid Embolization Agents 1.1 Definition of Uterine Fibroid Embolization Agents 1.2 Uterine Fibroid Embolization Agents Segment by Type 1.2.1 Global Uterine Fibroid Embolization Agents Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Gelatin Sponge 1.2.3 Polyvinyl Alcohol (PVA)
